The civic record
Read. Follow. Verify.Michigan restricts medical assistance coverage to lower-cost generic and interchangeable biological drugs
Last action · May 19, 2026: REFERRED TO COMMITTEE ON APPROPRIATIONSSponsor: Sarah Lightner
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
The bill would prohibit the state medical assistance program from covering brand name drugs or biological products when a lower-cost generic or interchangeable biological equivalent is available, subject to specific health code exceptions.
Changes drug coverage rules for state medical assistance participants and pharmacies by restricting brand-name prescriptions unless specific health code exemption criteria are met.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Medical assistance program participants
Participants may experience changes in prescription drug coverage options based on the availability of lower-cost generic or interchangeable biological equivalents.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Does this bill ban all brand name drugs under the medical assistance program?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed both. The next step in the legislative lifecycle is Law.
Procedural history
14 actions- May 19, 2026SenateCommitteeREFERRED TO COMMITTEE ON APPROPRIATIONS
- May 19, 2026SenateFloorPASSED BY HOUSE WITH IMMEDIATE EFFECT
- May 13, 2026Housetransmitted
- May 13, 2026HouseFloorpassed; given immediate effect Roll Call #142 Yeas 63 Nays 43 Excused 0 Not Voting 4
- May 13, 2026HouseFloorread a third time
- May 12, 2026Houseplaced on third reading
Show 8 earlier actions
- May 12, 2026HouseFloorsubstitute (H-1) adopted
- May 12, 2026HouseFloorread a second time
- Apr 29, 2026Housereferred to second reading
- Apr 29, 2026HouseCommitteereported with recommendation with substitute (H-1)
- Sep 9, 2025Housebill electronically reproduced 09/04/2025
- Sep 4, 2025HouseCommitteereferred to Committee on Appropriations
- Sep 4, 2025HouseIntroducedread a first time
- Sep 4, 2025HouseIntroducedintroduced by Representative Rep. Sarah Lightner
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Voting Record
passed; given immediate effect Roll Call #142 Yeas 63 Nays 43 Excused 0 Not Voting 4
Total
105
- Yes
- 63
- No
- 42
- Present
- 0
- Not voting
- 0
- Abstain
- 0
How they voted (105)
81 more members
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
legislature.mi.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
